In patients with locally advanced disease, positive LOXL2 expression was highly correlated with tumor T stage and lymph node metastasis, suggesting that LOXL2 may promote the progression of ESCC through its involvement in tumor proliferation and metastasis. The gene discussed is LOXL2; the disease is esophageal squamous cell carcinoma.